What is mariAST?

What is mariAST® platform?

mariAST® enables accurate resistance testing

  • The first platform to allow phenotypic resistance testing directly from polymicrobial clinical samples containing commensal flora, and not just “directly from positive blood cultures”
  • The only introduced platform capable of decentralized resistance testing and antibiotic susceptibility testing (AST)
  • It is widely known that phenotypic resistance testing offers more reliable results than genotypic testing
  • No compromise between assay sensitivity and result time
  • Applies the same fully automated and field proven TPX technology as the CE marked mariPOC®

mariAST®results allow you to take the right decisions

  • Pathogen- and strain-specific diagnosis and treatment
  • Accurate use of antimicrobials
  • Precise in-patient cohorting and fast discharge of contact isolation measures
  • Improved cost-effectiveness and patient flow management

What applications mariAST® is suitable for?

  • The technology provides most added value when the time to result matters, the number of plausible pathogens is limited and testing breakpoint antimicrobial concentration is enough
  • For example MRSA screening and testing, sexually transmitted diseases and non-penicillin susceptible pneumococci
  • Technically mariAST® enables also determination of MICs